Regeneron (NASDAQ: REGN) shares jumped over 20% after the company said on Thursday that its anti-blindness treatment Eylea, jointly developed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE